1. Home
  2. ANVS vs ALTS Comparison

ANVS vs ALTS Comparison

Compare ANVS & ALTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • ALTS
  • Stock Information
  • Founded
  • ANVS 2008
  • ALTS 1976
  • Country
  • ANVS United States
  • ALTS United States
  • Employees
  • ANVS N/A
  • ALTS N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • ALTS
  • Sector
  • ANVS Health Care
  • ALTS
  • Exchange
  • ANVS Nasdaq
  • ALTS NYSE
  • Market Cap
  • ANVS 31.2M
  • ALTS 72.7M
  • IPO Year
  • ANVS 2020
  • ALTS N/A
  • Fundamental
  • Price
  • ANVS $1.62
  • ALTS $4.17
  • Analyst Decision
  • ANVS Strong Buy
  • ALTS
  • Analyst Count
  • ANVS 5
  • ALTS 0
  • Target Price
  • ANVS $37.00
  • ALTS N/A
  • AVG Volume (30 Days)
  • ANVS 447.8K
  • ALTS 198.8K
  • Earning Date
  • ANVS 03-31-2025
  • ALTS 05-02-2025
  • Dividend Yield
  • ANVS N/A
  • ALTS N/A
  • EPS Growth
  • ANVS N/A
  • ALTS N/A
  • EPS
  • ANVS N/A
  • ALTS N/A
  • Revenue
  • ANVS N/A
  • ALTS $7,110,000.00
  • Revenue This Year
  • ANVS N/A
  • ALTS N/A
  • Revenue Next Year
  • ANVS N/A
  • ALTS N/A
  • P/E Ratio
  • ANVS N/A
  • ALTS N/A
  • Revenue Growth
  • ANVS N/A
  • ALTS N/A
  • 52 Week Low
  • ANVS $1.53
  • ALTS $1.29
  • 52 Week High
  • ANVS $20.00
  • ALTS $7.75
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 19.82
  • ALTS 39.61
  • Support Level
  • ANVS $1.57
  • ALTS $4.41
  • Resistance Level
  • ANVS $1.77
  • ALTS $4.91
  • Average True Range (ATR)
  • ANVS 0.18
  • ALTS 0.50
  • MACD
  • ANVS 0.07
  • ALTS -0.19
  • Stochastic Oscillator
  • ANVS 8.38
  • ALTS 15.24

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.

About ALTS ALT5 SIGMA CORPORATION

ALT5 Sigma Corp is a fintech company. It is providing next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment and safe-keeping of digital assets. The company product include ALT 5 Prime is an electronic over-the-counter trading platform and ALT 5 Pay crypto payment processor.

Share on Social Networks: